Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | PKM | P14618 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 6/20 | 0.51 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.47 |
| ▸ | HCAR3 | P49019 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GALR3 | O60755 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1886423 | 0.88 | ALDH1A1 (0.62) | ALDH1A1TSHRTDP1PKMMAPT | |
| SCHEMBL5983182 | 0.85 | KAT2B (0.69) | ALDH1A1TSHRTDP1PKMMAPT | |
| SCHEMBL29392416 | 0.83 | ALDH1A1 (0.68) | ALDH1A1TSHRTDP1PKMMAPT | |
| SCHEMBL127370 | 0.83 | ALDH1A1 (0.68) | ALDH1A1TSHRTDP1PKMMAPT | |
| SCHEMBL5017636 | 0.82 | ALDH1A1 (0.66) | ALDH1A1TSHRTDP1PKMMAPT | |
| SCHEMBL7719476 | 0.81 | TDP1 (0.42) | ALDH1A1TSHRTDP1PKMMAPT | |
| SCHEMBL8053888 | 0.80 | ALDH1A1 (0.63) | ALDH1A1TSHRTDP1PKMMAPT | |
| SCHEMBL29410422 | 0.80 | ALDH1A1 (0.63) | ALDH1A1TSHRTDP1PKMMAPT | |
| SCHEMBL563763 | 0.80 | PKM (0.67) | ALDH1A1TSHRTDP1PKMMAPT | |
| SCHEMBL24055 | 0.80 | ALDH1A1 (0.63) | ALDH1A1TSHRTDP1PKMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9504637-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| US-9248086-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. | 2015-06-25 | — | — | US | disclosed |
| US-7341604-B2 | Highly affine cosmetic agent | WELLA AG (DE) | 2008-03-11 | — | — | US | disclosed |
| US-20060174423-A1 | Highly affine cosmetic agent | Wella GmbH (DE) | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060174423-A1 | Highly affine cosmetic agent | TYR, ENO1, CUTA | ALDH1A1 1573/4885TSHR 787/4885TDP1 2803/4885 |
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | ALDH1A1 192/4885TSHR 4752/4885TDP1 841/4885 |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | ALDH1A1 192/4885TSHR 4752/4885TDP1 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.